Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $302.25 | 18 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $87.10 | 4 | $0 (2022) |
| Supernus Pharmaceuticals, Inc. | $69.30 | 5 | $0 (2022) |
| Lundbeck LLC | $43.56 | 3 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $39.33 | 2 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $31.73 | 2 | $0 (2021) |
| Alkermes, Inc. | $31.23 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $140.01 | 8 | Supernus Pharmaceuticals, Inc. ($44.45) |
| 2021 | $162.24 | 10 | AbbVie Inc. ($62.05) |
All Payment Transactions
18 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/14/2022 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $15.83 | General |
| Category: PSYCHOLOGY | ||||||
| 06/17/2022 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $13.68 | General |
| Category: PSYCHOLOGY | ||||||
| 05/12/2022 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.70 | General |
| Category: PSYCHIATRY | ||||||
| 04/29/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: NEUROSCIENCE | ||||||
| 04/20/2022 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $13.48 | General |
| Category: PSYCHIATRY | ||||||
| 03/24/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.05 | General |
| Category: NEUROSCIENCE | ||||||
| 02/17/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: NEUROSCIENCE | ||||||
| 01/17/2022 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $14.94 | General |
| Category: PSYCHOLOGY | ||||||
| 12/16/2021 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: PSYCHIATRY | ||||||
| 10/28/2021 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $12.38 | General |
| Category: PSYCHIATRY | ||||||
| 10/21/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: NEUROSCIENCE | ||||||
| 08/11/2021 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: CNS | ||||||
| 06/17/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $13.50 | General |
| Category: PSYCHOLOGY | ||||||
| 06/02/2021 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: CNS | ||||||
| 05/27/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $11.35 | General |
| Category: PSYCHOLOGY | ||||||
| 04/20/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.77 | General |
| Category: NEUROSCIENCE | ||||||
| 03/16/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.51 | General |
| Category: NEUROSCIENCE | ||||||
| 02/03/2021 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $12.36 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 1 | 25 | 162 | $19,777 | $8,631 |
All Medicare Procedures & Services
1 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 25 | 162 | $19,777 | $8,631 | 43.6% |
About Tabitha Roach, APRN
Tabitha Roach, APRN is a Psychiatric/Mental Health healthcare provider based in Fort Knox, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/13/2020. The National Provider Identifier (NPI) number assigned to this provider is 1336761253.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Tabitha Roach, APRN has received a total of $302.25 in payments from pharmaceutical and medical device companies, with $140.01 received in 2022. These payments were reported across 18 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($302.25).
As a Medicare-enrolled provider, Roach has provided services to 25 Medicare beneficiaries, totaling 162 services with total Medicare billing of $8,631. Data is available for 1 year (2021–2021), covering 1 distinct procedure/service records.
Practice Information
- Specialty Psychiatric/Mental Health
- Other Specialties Psychiatric/Mental Health, Psychiatric/Mental Health
- Location Fort Knox, KY
- Active Since 05/13/2020
- Last Updated 06/26/2025
- Taxonomy Code 163WP0808X
- Entity Type Individual
- NPI Number 1336761253
Products in Payments
- VRAYLAR (Drug) $87.10
- QELBREE (Drug) $69.30
- REXULTI (Drug) $55.92
- TRINTELLIX (Drug) $39.33
- ARISTADA (Drug) $31.23
- ABILIFY MAINTENA (Drug) $19.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Fort Knox
Linda Anderson, Arnp, ARNP
Psychiatric/Mental Health
Ms. Rebecca Hardie, Arnp,Bc Msn Cs, ARNP,BC MSN CS
Psychiatric/Mental Health
Ms. Lakisha Wright
Psychiatric/Mental Health
Kayla Henderson, Aprn, APRN
Psychiatric/Mental Health